Lidotor Interactions
There are 83 drugs known to interact with Lidotor (lidocaine / prilocaine topical), along with 7 disease interactions. Of the total drug interactions, 43 are major, 33 are moderate, and 7 are minor.
- View all 83 medications that may interact with Lidotor
- View Lidotor disease interactions (7)
Most frequently checked interactions
View interaction reports for Lidotor (lidocaine / prilocaine topical) and the medicines listed below.
- acyclovir
- Alphagan P (brimonidine ophthalmic)
- Breo Ellipta (fluticasone / vilanterol)
- Centrum Silver (multivitamin with minerals)
- clonazepam
- Darzalex Faspro (daratumumab / hyaluronidase)
- Fentanyl Transdermal System (fentanyl)
- gabapentin
- lamotrigine
- Levoxyl (levothyroxine)
- Lidocan Patch (lidocaine topical)
- lithium
- Lumigan (bimatoprost ophthalmic)
- magnesium glycinate
- Marinol (dronabinol)
- Mestinon (pyridostigmine)
- MiraLAX (polyethylene glycol 3350)
- Nexium 24HR (esomeprazole)
- Ocuvite Adult 50+ (multivitamin with minerals)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- oxycodone
- Pemgarda (pemivibart)
- Privigen (immune globulin intravenous)
- Robaxin (methocarbamol)
- Singulair (montelukast)
- Soolantra (ivermectin topical)
- Vitamin D3 (cholecalciferol)
- vitamin e
- Xopenex Concentrate (levalbuterol)
- Xopenex HFA (levalbuterol)
Lidotor disease interactions
There are 7 disease interactions with Lidotor (lidocaine / prilocaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- methemoglobinemia
- renal/hepatic dysfunction
More about Lidotor (lidocaine / prilocaine topical)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.